SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Poly Medicure reports 34% jump in Q4 consolidated net profit

07 May 2025 Evaluate

Poly Medicure has reported results for fourth quarter (Q4) and year ended March 31, 2025.

The company has reported 22.87% rise in its net profit at Rs 86.66 crore for the quarter under review as compared to Rs 70.53 crore for the same quarter in the previous year. The total income of the company increased by 18.14% at Rs 444.92 crore for Q4FY25 as compared Rs 376.59 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 34.33% rise in its net profit at Rs 91.83 crore for fourth quarter ended March 31, 2025 as compared to Rs 68.36 crore for the same quarter in the previous year. The total income of the company increased by 18.34% at Rs 465.14 crore for Q4FY25 as compared Rs 393.05 crore for the corresponding quarter previous year. 

For the year ended March 31, 2025, the company has reported 31.63% rise in its net profit at Rs 331.33 crore as compared to Rs 251.72 crore for the previous year. The total income of the company increased by 23.89% at Rs 1691.57 crore for year under review as compared to Rs 1365.43 crore for year ended March 31, 2024.

For the year ended March 31, 2025, on the consolidated basis, the company has reported 31.09% rise in its net profit at Rs 338.56 crore as compared to Rs 258.26 crore for the previous year. The total income of the company increased by 22.62% at Rs 1758.96 crore for year under review as compared to Rs 1434.54 crore for year ended March 31, 2024.

Poly Medicure Share Price

1497.15 24.65 (1.67%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 539.80
Poly Medicure 1497.15
Laxmi Denta 198.55
Nureca Ltd. 262.50
Hemant Surgical Inds 296.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×